They Rarely Ask for Pain Pills Now
When I was in my residency training, from 1990-1993, we were in the nascent phase of the ‘pain is a ...
Lawmakers Trying to Remove Licensing Hurdles for Social Workers
Lawmakers are navigating licensing law hurdles so patients can benefit from increased access to social workers.
Biden Administration Makes Right Investments in Mental Health But More Changes Needed
We’ve seen an enormous spike in mental health problems among children—all of which were exacerbated by the COVID pandemic.
Flipping COINs to COPINs
Collaborative Innovation Networks (COINs) have mushroomed since the invention of the Internet and cheap mobile communications.
The Story Behind the Stories in Medicine on Fire
The phrase "medicine is on fire" is often used metaphorically to describe the challenges and pressures that the healthcare industry ...
Health Misinformation is on the Ballot
Election cycles are notable for the spread of misinformation. This year, we will see an unprecedented rise in health misinformation.
To Explain Pain as a Patient
The fact that I’m the one who’s feeling it; your perception may not include what we feel, but can you ...
Healthcare in Space
Anyone familiar with America’s space program will recognize that this nation went through a coma of innovation due to self-inflicted ...
My Struggle to Chronicle Patients
My mission is not only to provide healthcare to my patients but also to shed light on the challenges they ...
Documentation Fraud in the BOP
Documentation fraud is the root cause of poor healthcare in the Bureau of Prisons. Until that's addressed, no improvements will ...
GoFundMe is Now Standard of Care
“I’d been through the gamut and just cried,” she said. She said she would like to repay the people who ...
A Poem on Stress Management
Medications used to treat anxiety aren’t always an option for various reasons and some examples may include lack of access ...
FDA Evaluation of Certain Bulk Drug Substances in Compounding: Clinical Interpretation
Clinicians increasingly encounter patients using or requesting peptide-based therapies sourced through compounding pharmacies. The U.S. Food and Drug Administration has identified a subset of bulk drug substances, including certain peptides, that may present significant safety risks when used in compounded formulations. The clinical question is whether these regulatory signals reflect meaningful patient-level risk and how they should influence prescribing behavior. This matters because compounded peptides often sit outside traditional approval pathways, creating uncertainty around quality, dosing consistency, and safety. Understanding...
Read morePopular
-
GLP-1 Agonists Beyond Obesity: The Expanding Therapeutic and Optimization Frontier
-
The IRA’s Drug Negotiation Mechanism Meets the Rebate Industrial Complex
-
Growth Hormone Secretagogues and the Longevity Trade-Off
-
The Second Reader That Never Sleeps: Large Language Models and Clinical Decision-Making
-
The Peptide Underground: Clinical Evidence, Compounding Markets, and the Optimization Economy
